PMV Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
PMV Pharmaceuticals Inc
TickerPMVP
CIK #0001699382
CUSIP69353Y103
SectorLife Sciences - Pharmaceutical Preparations
Address8 Clarke Drive, Cranbury, NJ 08512
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
PMV Pharmaceuticals Inc 2017-03-02 73.7 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001699382] 10-K
[0001699382] 10-Q
[0001699382] 3
[0001699382] 4
[0001699382] 8-K
[0001699382] D
[0001699382] SC 13D
[0001699382] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
SIO Capital Management LLC PMV Pharmaceuticals Inc [2025-04-08] 0.0
PFM Health Sciences LP PMV Pharmaceuticals Inc [2025-02-21] 0.0
SIO Capital Management LLC PMV Pharmaceuticals Inc [2025-02-10] 0.0
BML Investment Partners LP PMV Pharmaceuticals Inc [2024-12-12] 6.3
ArrowMark Colorado Holdings LLC PMV Pharmaceuticals Inc [2024-02-14] 5.31
Citadel Advisors LLC PMV Pharmaceuticals Inc [2023-05-19] 3.3
State Street Corp PMV Pharmaceuticals Inc [2022-07-11] 11.35
Citadel Advisors LLC PMV Pharmaceuticals Inc [2022-06-17] 3.1
RTW Investments LP PMV Pharmaceuticals Inc [2022-02-14] 6.6
Vanguard Group Inc PMV Pharmaceuticals Inc [2022-02-10] 5.84
BlackRock Inc PMV Pharmaceuticals Inc [2022-02-04] 5.6
JPMorgan Chase & Co PMV Pharmaceuticals Inc [2022-01-26] 6.9
Cowen Financial Products LLC PMV Pharmaceuticals Inc [2022-01-19] 5.07
Nextech V Oncology SCS SICAV-SIF PMV Pharmaceuticals Inc [2021-02-16] 5.6
InterWest Partners X LP PMV Pharmaceuticals Inc [2021-02-12] 14.5
Euclidean Capital LLC PMV Pharmaceuticals Inc [2021-02-12] 9.3
Avoro Capital Advisors LLC PMV Pharmaceuticals Inc [2021-02-12] 5.3
OrbiMed Advisors LLC PMV Pharmaceuticals Inc [2020-10-05] 14.7
Viking Global Investors LP PMV Pharmaceuticals Inc [2020-10-05] 6.1
Boxer Capital LLC PMV Pharmaceuticals Inc [2020-09-30] 0.0
Form 3/4/5 Filer 2011 - 2026
PMV Pharmaceuticals Inc
Levine Arnold J
Stelzer Laurie
Flowers Kirsten
Gallagher Carol Giltner
BAUM Charles M
Mack David Henry
Jalota Deepika
Carulli Michael
Ticktin Robert
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Heyman Richard A
OrbiMed Genesis GP LLC
Alland Leila
Kung Winston
OrbiMed Capital LLC
Schroeder Thilo
Desai Keval
Nasr Khaled
InterWest Venture Management Company
Kliman Gilbert H
InterWest Partners X LP
Simons James H
Euclidean Capital LLC
Symmetry Group Ltd
Greenland FP LLC
Greenland NFP LLC
Greenland NFP B Ltd
Chhabra Ashvin
Greenland A LLC
Simons Marilyn
Thompson Peter A
Davis Aaron I
Lewis Joseph
MVA Investors LLC
Boxer Asset Management Inc
Boxer Capital LLC
Oronsky Arnold L
Wellington Biomedical Innovation Master Investors Cayman I
Double Epiphany LLC
Levine Alison
Dawson Samantha
Shah Rajeev M
Kolchinsky Peter
RA Capital Management LP
Nextech V Oncology SCS SICAV-SIF
Lips Thomas
Bleyer Dalia
Detournay Philippe
Nextech V GP Sa RL
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Carulli Michael
Employee Stock Option (right to buy) · derivative
2026-03-05 Grant 240,000 $0.00
Jalota Deepika
Employee Stock Option (right to buy) · derivative
2026-03-05 Grant 303,310 $0.00
Ticktin Robert
Employee Stock Option (right to buy) · derivative
2026-03-05 Grant 319,270 $0.00
Mack David Henry
Employee Stock Option (right to buy) · derivative
2026-03-05 Grant 744,960 $0.00
Mack David Henry
Common Stock
2025-10-27 Option exercise 220,643 $1.37 302,281
Mack David Henry
Employee Stock Option (right to buy) · derivative
2025-10-27 Option exercise 220,643 $0.00
OrbiMed Advisors LLC +1
Common Stock
2025-10-23 Sell 1,000,000 $1.52 1,520,000
Common Stock
2025-09-10 Sell 500,000 $1.80 900,000
Jalota Deepika
Common Stock
2025-07-01 Sell 33,065 $1.06 35,049
Mack David Henry
Common Stock
2025-07-01 Sell 58,411 $1.06 61,916
Carulli Michael
Common Stock
2025-07-01 Sell 28,249 $1.06 29,944
Ticktin Robert
Common Stock
2025-07-01 Sell 23,151 $1.06 24,540
BAUM Charles M
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
Levine Arnold J
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
Gallagher Carol Giltner
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
Heyman Richard A
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
Stelzer Laurie
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
Gallagher Carol Giltner
Stock Option (right to buy) · derivative
2025-06-05 Gift 33,500 $0.00
Gallagher Carol Giltner
Stock Option (right to buy) · derivative
2025-06-05 Gift 33,500 $0.00
Flowers Kirsten
Stock Option (right to buy) · derivative
2025-06-05 Grant 33,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 69 34,832,057
2025-12-31 63 35,619,794
2025-09-30 64 35,415,059
2025-06-30 56 32,618,927
2025-03-31 56 35,277,082
2024-12-31 71 36,883,420
2024-09-30 75 36,952,914
2024-06-30 94 38,617,072
2024-03-31 100 41,628,466
2023-12-31 100 50,193,596
2023-09-30 107 57,700,794
2023-06-30 107 51,733,847
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 330,003 330,003
Accurate Wealth Management LLC [2026-06-30] SOLE 0 50,000
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com